Psychiatrie et violence : quel est le risque acceptable ?

L'évolution des connaissances et des compétences en matière d'évaluation et de gestion du risque de violence a permis une indiscutable avancée. Néanmoins les instruments utilisés restent encore source de controverses et prêtent le flanc à de nombreuses critiques. Dans ce contexte le climat sécuritaire actuel fait peser une lourde pression sur les équipes soignantes qui ont aussi à faire face à la violence des patients. Une réflexion sur les possibilités et les limites autant du soin que de la privation de liberté permet, peut-être d'envisager ce qu'est un risque acceptable. Evolution of knowledge and skills in violence risk management and assessment allowed an indisputable progress. Nevertheless instruments used such as HCR-20 still remain source of controversy and gives occurrence to numerous criticisms. In this context, the current high security climate puts added pressure on the medical teams which also have to deal with the violence of patients. A reflection on the possibilities and the limits of care as well as freedom deprivation may allow us to envision what is an acceptable risk.

La reconnaissance des couples homosexuels. Enjeux juridiques, sociaux et religieux

Cet ouvrage propose de poser les questions éthiques que suscitent notamment l'instauration du PACS en France, le débat sur l'intégration des couples homosexuels dans les Eglises et plus largement l'évolution des moeurs en la matière. Fruit d'un colloque organisé par l'Institut romand d'éthique, cet ouvrage accueille des auteurs d'horizons et de nationalités divers, parmi lesquels on trouve notamment Dominique Fernandez et Irène Théry.

Circulating soluble CR1 (CD35). Serum levels in diseases and evidence for its release by human leukocytes.

C receptor type 1 (CR1, CD35) is present in a soluble form in plasma (sCR1). Soluble CR1 was measured with a specific ELISA assay in normal individuals and in patients with different diseases. The mean serum concentration of sCR1 in 31 normal donors was 31.4 +/- 7.8 ng/ml, and was identical in plasma. An increase in sCR1 was observed in 36 patients with end-stage renal failure on dialysis (54.8 +/- 11.7 ng/ml, p < 0.0001), and in 22 patients with liver cirrhosis (158.3 +/- 49.9 ng/ml, p < 0.0001). The mean sCR1 levels dropped from 181 +/- 62.7 to 52.1 +/- 24.0 ng/ml (p < 0.001) in nine patients who underwent liver transplantation, and was 33.5 +/- 7.3 in 10 patients with functioning renal grafts, indicating that the increase in sCR1 was reversible. Soluble CR1 was elevated in some hematologic malignancies (> 47 ng/ml), which included B cell lymphoma (12/19 patients), Hodgkin's lymphoma (4/4), and chronic myeloproliferative syndromes (4/5). By contrast, no increase was observed in acute myeloid or lymphoblastic leukemia (10) or myeloma (5). In two patients with chronic myeloproliferative syndromes, sCR1 decreased rapidly after chemotherapy. The mean concentration of sCR1 was not significantly modified in 181 HIV-infected patients at various stages of the disease (34.8 +/- 14.4 ng/ml), and in 13 patients with active SLE (38.3 +/- 19.6 ng/ml), although in both groups the number of CR1 was diminished on E. There was a weak but significant correlation between sCR1 and CR1 per E in HIV infection and SLE (r = 0.39, p < 0.0001, and r = 0.60, p < 0.03 respectively). In vitro, monocytes, lymphocytes, and neutrophils were found to release sCR1 into culture supernatants. In vivo, sCR1 was detected in the serum of SCID mice populated with human peripheral blood leukocytes. The sCR1 levels correlated with those of human IgG (r = 0.97, p < 0.0001), suggesting synthesis of sCR1 by the transferred lymphocytes. The mechanisms underlining the increased levels of sCR1 and its biologic consequences remain to be defined.

Evaluation des campagnes de prévention contre le SIDA en Suisse : rapport de l'étude "homosexuels" : novembre 1987

Cette étude est destinée à évaluer les effets des campagnes de prévention du SIDA en Suisse chez les homosexuels, en termes de modifications des représentations, attitudes et comportements face à cette maladie et aux manières de s'en protéger. Elle s'intéresse aussi aux modalités d'acquisition d'attitudes et comportements nouveaux, ainsi qu'à la manière dont les campagnes ont été accueillies et répercutées. (Questionnaire en annexe).

Le "je" ovidien et le traducteur: la traduction contemporaine des "Tristes" et des "Pontiques" en France

Cette thèse de doctorat traite de cinq traductions françaises des Tristes et des Pontiques d'Ovide parues depuis le second tiers du XXe siècle : celles d'Emile Ripert (1937), de Jacques André (1968-1977), de Dominique Poirel (1989), de Chantai Labre (1991) et de Marie Darrieussecq (2008).¦Les deux oeuvres latines, recueils de lettres élégiaques écrites à la première personne, semblent proposer une réflexion sur le statut du ego qui désigne leur protagoniste, poète romain exilé par Auguste. En effet, ce « je » peut se percevoir tantôt comme le reflet spontané de la personne du poète, dans la mesure où la visée d'Ovide est explicitement autobiographique, tantôt comme le produit d'une construction littéraire, inspiré d'oeuvres de fiction. Dans la critique des XXe et XXIe siècles, la question de savoir comment s'articule le rapport, dans les poèmes d'exil, entre l'oeuvre écrite et la réalité historique, entre le «je» textuel et le « je » de l'auteur, a donné Heu à des réponses très variées.¦Dans un premier temps, l'objectif de l'analyse est de montrer qu'un débat similaire se dessine dans les traductions de la même période, que chaque traducteur des Tristes et des Pontiques, à travers des choix lexicaux et stylistiques bien particuliers, par le biais de commentaires prenant place dans le paratexte de la traduction, fournit au lecteur une image différente du « je » ovidien.¦La seconde étape se concentre sur le processus d'appropriation qui sous-tend la traduction. Les caractéristiques du « je » ovidien, telles qu'elles transparaissent dans la traduction, sont mises en lien avec l'image d'auteur, la poétique ou l'approche interprétative qui ressortent de l'ensemble des productions du traducteur (traductions, oeuvres de commentaire, créations littéraires etc.).¦La troisième partie de l'analyse s'interroge sur la manière dont le traducteur envisage sa pratique et se représente lui-même, dans sa préface ou à travers sa poétique de la traduction, en tant que traducteur. En comparant l'image qu'il montre de lui-même avec celle que sa traduction renvoie de l'auteur du texte original, on observe des similitudes qui suggèrent la parenté de la traduction et de la création littéraire.

Evaluation of different POCT devices for glucose measurement in a clinical neonatal setting.

Hypoglycaemia is a major cause of neonatal morbidity and may induce long-term developmental sequelae. Clinical signs of hypoglycaemia in neonatal infants are unspecific or even absent, and therefore, precise and accurate methods for the assessment of glycaemia are needed. Glycaemia measurement in newborns has some particularities like a very low limit of normal glucose concentration compared to adults and a large range of normal haematocrit values. Many bedside point-of-care testing (POCT) systems are available, but literature about their accuracy in newborn infants is scarce and not very convincing. In this retrospective study, we identified over a 1-year study period 1,324 paired glycaemia results, one obtained at bedside with one of three different POCT systems (Elite? XL, Ascensia? Contour? and ABL 735) and the other in the central laboratory of the hospital with the hexokinase reference method. All three POCT systems tended to overestimate glycaemia values, and none of them fulfilled the ISO 15197 accuracy criteria. The Elite XL appeared to be more appropriate than Contour to detect hypoglycaemia, however with a low specificity. Contour additionally showed an important inaccuracy with increasing haematocrit. The bench analyzer ABL 735 was the most accurate of the three tested POCT systems. Both of the tested handheld glucometers have important drawbacks in their use as screening tools for hypoglycaemia in newborn infants. ABL 735 could be a valuable alternative, but the blood volume needed is more than 15 times higher than for handheld glucometers. Before daily use in the newborn population, careful clinical evaluation of each new POCT system for glucose measurement is of utmost importance.

Drug monographs on drugs which are frequently analysed in the context of Therapeutic Drug Monitoring = Arzneimittel-Monographien für Medikamente, die regelmässig im Rahmen des Therapeutic Drug Monitorings analysiert werden

In addition to the monographs which were published last year by the working group "Drug Monitoring" of the Swiss Society of Clinical Chemistry (SSCC) [1], new monographs have been written. The aim of these monographs is to give an overview of the most important information necessary for ordering a drug analysis or interpreting the results. Therefore, the targeted readers comprise laboratory health professionals and all receivers of laboratory reports. There is information provided on the indication for therapeutic drug monitoring, protein binding, metabolic pathways and enzymes involved, elimination half-life and elimination routes, and on therapeutic or toxic concentrations. Preanalytical considerations are of particular importance for therapeutic drug monitoring. Therefore, information is provided regarding a reasonable timing for the determination of drug concentrations as well as steady-state concentrations after changing the dose. Furthermore, the stability of the drug and its metabolite(s) after blood sampling is described. For readers with a specific interest in drug analysis, references to important publications are given. The number of monographs will be continuously enlarged. The updated files are presented on the homepage of the SSCC (www.sscc.ch).

PAP1 [poly(A) polymerase 1] homozygosity and hyperadenylation are major determinants of increased mRNA stability of CDR1 in azole-resistant clinical isolates of Candida albicans.

Using genetically matched azole-susceptible (AS) and azole-resistant (AR) clinical isolates of Candida albicans, we recently demonstrated that CDR1 overexpression in AR isolates is due to its enhanced transcriptional activation and mRNA stability. This study examines the molecular mechanisms underlying enhanced CDR1 mRNA stability in AR isolates. Mapping of the 3' untranslated region (3' UTR) of CDR1 revealed that it was rich in adenylate/uridylate (AU) elements, possessed heterogeneous polyadenylation sites, and had putative consensus sequences for RNA-binding proteins. Swapping of heterologous and chimeric lacZ-CDR1 3' UTR transcriptional reporter fusion constructs did not alter the reporter activity in AS and AR isolates, indicating that cis-acting sequences within the CDR1 3' UTR itself are not sufficient to confer the observed differential mRNA decay. Interestingly, the poly(A) tail of the CDR1 mRNA of AR isolates was approximately 35-50 % hyperadenylated as compared with AS isolates. C. albicans poly(A) polymerase (PAP1), responsible for mRNA adenylation, resides on chromosome 5 in close proximity to the mating type-like (MTL) locus. Two different PAP1 alleles, PAP1-a/PAP1-alpha, were recovered from AS (MTL-a/MTL-alpha), while a single type of PAP1 allele (PAP1-alpha) was recovered from AR isolates (MTL-alpha/MTL-alpha). Among the heterozygous deletions of PAP1-a (Deltapap1-a/PAP1-alpha) and PAP1-alpha (PAP1-a/Deltapap1-alpha), only the former led to relatively enhanced drug resistance, to polyadenylation and to transcript stability of CDR1 in the AS isolate. This suggests a dominant negative role of PAP1-a in CDR1 transcript polyadenylation and stability. Taken together, our study provides the first evidence, to our knowledge, that loss of heterozygosity at the PAP1 locus is linked to hyperadenylation and subsequent increased stability of CDR1 transcripts, thus contributing to enhanced drug resistance.

Evaluation des campagnes de prévention contre le SIDA en Suisse : Kantonale Aktivitaeten der Aidspraevention : November 1987

Die Untersuchung verfolgt mehrere Ziele: -> erstens soll der Informationsstand über die Aktivitäten zur Aidsbekämpfung in den Kantonen erhöht werden, -> zweitens sollen Lösungsmodelle bezüglich des Umgangs mit dem Problem vergleichen dargestellt werden, -> drittens sollen Erkenntnisse darüber gesammelt werden, welche Individuen sich als besonders gute Vermittler präventiver Botschaften eignen.